Drugs / Intravenous Immunoglobulin
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2/3 | NCT00194987 | Apr 2001 → Jun 2015 | fetal and neonatal alloimmune thrombocytopenia, thrombocytopenia | Weill Medical College of Cornell University | Completed | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Intravenous Immunoglobulin | “IVIG (Intravenous Immunoglobulin)” NCT00194987 ↗ |
| Known as | IVIG | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00194987 ↗ |
| Modality | Protein / enzyme biologic | “IVIG (Intravenous Immunoglobulin)” NCT00194987 ↗ |
| Route | Intravenous | “intravenous immunoglobulin (IVIG)” NCT00194987 ↗ |